Literature DB >> 20494659

Frequency of abdominal aortic aneurysm in patients undergoing coronary artery bypass grafting.

Annabelle Dupont1, Ahmed Elkalioubie, Francis Juthier, Madjid Tagzirt, André Vincentelli, Thierry Le Tourneau, Stéphan Haulon, Ghislaine Deklunder, Joke Breyne, Sophie Susen, Sylvestre Marechaux, Florence Pinet, Brigitte Jude.   

Abstract

The aims of this study were to clarify the prevalence and the risk factors for unsuspected abdominal aortic aneurysm (AAA) in patients who underwent coronary artery bypass grafting for severe coronary artery disease and to identify the most at risk patients for AAA. Among 217 patients (189 men, mean age 64 +/- 11 years), asymptomatic AAAs, as prospectively identified by echocardiography, were found in 15 patients (6.9%). All patients with AAAs were men and smokers or past smokers. Factors significantly associated by univariate analysis with asymptomatic AAA presence were smoking (p = 0.003), symptomatic peripheral artery disease (p = 0.006), significant carotid artery stenosis (p = 0.007), and larger femoral and popliteal diameters (p = 0.008 and p = 0.0012, respectively). The other classic demographic, clinical, and biologic features were equally distributed among patients. In conclusion, in patients who underwent coronary artery bypass grafting who were men and aged <75 years with smoking histories, the prevalence of AAA was as high as 24% when they had concomitant peripheral arterial disease and/or carotid artery stenosis (vs 4.4% in the absence of either condition, p = 0.007), justifying consideration of AAA screening in this subgroup of in-hospital patients. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20494659     DOI: 10.1016/j.amjcard.2010.01.011

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Screening of Abdominal Aortic Aneurysm Using Portable Transthoracic Echocardiography among Patients with Acute Coronary Syndrome.

Authors:  Yousef Shukha; Ofir Koren; Tsafrir Or; Yoav Turgeman; Mahmud Mahamid; Mohamed Jabaren
Journal:  Cardiol Res Pract       Date:  2020-06-27       Impact factor: 1.866

Review 2.  ACR Appropriateness Criteria® pulsatile abdominal mass, suspected abdominal aortic aneurysm.

Authors:  Benoit Desjardins; Karin E Dill; Scott D Flamm; Christopher J Francois; Marie D Gerhard-Herman; Sanjeeva P Kalva; M Ashraf Mansour; Emile R Mohler; Isabel B Oliva; Matthew P Schenker; Clifford Weiss; Frank J Rybicki
Journal:  Int J Cardiovasc Imaging       Date:  2012-05-27       Impact factor: 2.357

3.  Quantitative mass spectrometry analysis using PAcIFIC for the identification of plasma diagnostic biomarkers for abdominal aortic aneurysm.

Authors:  Adelina E Acosta-Martin; Alexandre Panchaud; Maggy Chwastyniak; Annabelle Dupont; Francis Juthier; Corinne Gautier; Brigitte Jude; Philippe Amouyel; David R Goodlett; Florence Pinet
Journal:  PLoS One       Date:  2011-12-07       Impact factor: 3.240

4.  Screening for abdominal aortic aneurysm during transthoracic echocardiography in patients with significant coronary artery disease.

Authors:  Sung Ho Lee; Sung-A Chang; Shin Yi Jang; Sang-Chol Lee; Young Bin Song; Seung Woo Park; Seung-Hyuk Choi; Hyeon-Cheol Gwon; Jae K Oh; Duk-Kyung Kim
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

5.  The interplay between abdominal aortic aneurysm, metabolic syndrome and fatty liver disease: a retrospective case-control study.

Authors:  Mahmud Mahamid; Tawfik Khoury; Baker Mahamid; Wisam Sbeit; Amir Mari; Wiliam Nseir
Journal:  Diabetes Metab Syndr Obes       Date:  2019-09-04       Impact factor: 3.168

6.  Screening for Prevalence of Abdominal Aortic Aneurysm During Transthoracic Echocardiography in Patient With Significant Coronary Artery Disease.

Authors:  Pravesh Vishwakarma; Panduranga Patwari; Akshyaya Pradhan; Monika Bhandari; Rishi Sethi; Sharad Chandra; Gaurav Chaudhary; Akhil Sharma; Sudhanshu Kumar Dwivedi; Varun Shankar Narain
Journal:  Cardiol Res       Date:  2021-08-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.